These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 28750923)

  • 1. Didox (3,4-dihydroxybenzohydroxamic acid) suppresses IL-33-induced cytokine production in primary mouse mast cells.
    Caslin HL; McLeod JJA; Spence AJ; Qayum AA; Kolawole EM; Taruselli MT; Paranjape A; Elford HL; Ryan JJ
    Cell Immunol; 2017 Sep; 319():10-16. PubMed ID: 28750923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Didox (3,4-dihydroxybenzohydroxamic acid) suppresses IgE-mediated mast cell activation through attenuation of NFκB and AP-1 transcription.
    McLeod JJA; Caslin HL; Spence AJ; Kolawole EM; Qayum AA; Paranjape A; Taruselli M; Haque TT; Kiwanuka KN; Elford HL; Ryan JJ
    Cell Immunol; 2017 Dec; 322():41-48. PubMed ID: 28964543
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-13 suppresses TNF-induced activation of nuclear factor-kappa B, activation protein-1, and apoptosis.
    Manna SK; Aggarwal BB
    J Immunol; 1998 Sep; 161(6):2863-72. PubMed ID: 9743347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-9 and IL-13 production by activated mast cells is strongly enhanced in the presence of lipopolysaccharide: NF-kappa B is decisively involved in the expression of IL-9.
    Stassen M; Müller C; Arnold M; Hültner L; Klein-Hessling S; Neudörfl C; Reineke T; Serfling E; Schmitt E
    J Immunol; 2001 Apr; 166(7):4391-8. PubMed ID: 11254693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. TGF-β1 Suppresses IL-33-Induced Mast Cell Function.
    Ndaw VS; Abebayehu D; Spence AJ; Paez PA; Kolawole EM; Taruselli MT; Caslin HL; Chumanevich AP; Paranjape A; Baker B; Barnstein BO; Haque TT; Kiwanuka KN; Oskeritzian CA; Ryan JJ
    J Immunol; 2017 Aug; 199(3):866-873. PubMed ID: 28637902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular regulation of interleukin-13 and monocyte chemoattractant protein-1 expression in human mast cells by interleukin-1beta.
    Lee SA; Fitzgerald SM; Huang SK; Li C; Chi DS; Milhorn DM; Krishnaswamy G
    Am J Respir Cell Mol Biol; 2004 Sep; 31(3):283-91. PubMed ID: 15191916
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-evaluation of IL-10 signaling reveals novel insights on the contribution of the intracellular domain of the IL-10R2 chain.
    Wilbers RHP; van Raaij DR; Westerhof LB; Bakker J; Smant G; Schots A
    PLoS One; 2017; 12(10):e0186317. PubMed ID: 29016674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dexamethasone rapidly suppresses IL-33-stimulated mast cell function by blocking transcription factor activity.
    Paranjape A; Chernushevich O; Qayum AA; Spence AJ; Taruselli MT; Abebayehu D; Barnstein BO; McLeod JJ; Baker B; Bajaj GS; Chumanevich AP; Oskeritzian CA; Ryan JJ
    J Leukoc Biol; 2016 Dec; 100(6):1395-1404. PubMed ID: 27443878
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Saucerneol F inhibits tumor necrosis factor-α and IL-6 production by suppressing Fyn-mediated pathways in FcεRI-mediated mast cells.
    Lu Y; Piao D; Zhang H; Li X; Chao GH; Park SJ; Chang YC; Kim CH; Murakami M; Jung SH; Choi JH; Son JK; Chang HW
    Food Chem Toxicol; 2013 Sep; 59():696-702. PubMed ID: 23851146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ceramide inhibits LPS-induced production of IL-5, IL-10, and IL-13 from mast cells.
    Chiba N; Masuda A; Yoshikai Y; Matsuguchi T
    J Cell Physiol; 2007 Oct; 213(1):126-36. PubMed ID: 17458900
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-inflammatory effect of Poncirus trifoliata fruit through inhibition of NF-kappaB activation in mast cells.
    Shin TY; Oh JM; Choi BJ; Park WH; Kim CH; Jun CD; Kim SH
    Toxicol In Vitro; 2006 Oct; 20(7):1071-6. PubMed ID: 16574371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-33 induces IL-13 production by mouse mast cells independently of IgE-FcepsilonRI signals.
    Ho LH; Ohno T; Oboki K; Kajiwara N; Suto H; Iikura M; Okayama Y; Akira S; Saito H; Galli SJ; Nakae S
    J Leukoc Biol; 2007 Dec; 82(6):1481-90. PubMed ID: 17881510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lactic Acid Suppresses IL-33-Mediated Mast Cell Inflammatory Responses via Hypoxia-Inducible Factor-1α-Dependent miR-155 Suppression.
    Abebayehu D; Spence AJ; Qayum AA; Taruselli MT; McLeod JJ; Caslin HL; Chumanevich AP; Kolawole EM; Paranjape A; Baker B; Ndaw VS; Barnstein BO; Oskeritzian CA; Sell SA; Ryan JJ
    J Immunol; 2016 Oct; 197(7):2909-17. PubMed ID: 27559047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IgE production in CD40/CD40L cross-talk of B and mast cells and mediator release via TGase 2 in mouse allergic asthma.
    Hong GU; Park BS; Park JW; Kim SY; Ro JY
    Cell Signal; 2013 Jun; 25(6):1514-25. PubMed ID: 23524335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The efficacy of the ribonucleotide reductase inhibitor Didox in preclinical models of AML.
    Cook GJ; Caudell DL; Elford HL; Pardee TS
    PLoS One; 2014; 9(11):e112619. PubMed ID: 25402485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcineurin-Rcan1 interaction contributes to stem cell factor-mediated mast cell activation.
    Wu Z; Li Y; MacNeil AJ; Junkins RD; Berman JN; Lin TJ
    J Immunol; 2013 Dec; 191(12):5885-94. PubMed ID: 24218457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Foxp3(+)-Treg cells enhanced by repeated low-dose gamma-irradiation attenuate ovalbumin-induced allergic asthma in mice.
    Park BS; Hong GU; Ro JY
    Radiat Res; 2013 May; 179(5):570-83. PubMed ID: 23560633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of allergic airway inflammation through Toll-like receptor 4-mediated modification of mast cell function.
    Nigo YI; Yamashita M; Hirahara K; Shinnakasu R; Inami M; Kimura M; Hasegawa A; Kohno Y; Nakayama T
    Proc Natl Acad Sci U S A; 2006 Feb; 103(7):2286-91. PubMed ID: 16461458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Opposite effects of Trichostatin A on activation of mast cells by different stimulants.
    Wang QH; Nishiyama C; Nakano N; Kanada S; Hara M; Kitamura N; Shimokawa N; Lu CL; Ogawa H; Okumura K
    FEBS Lett; 2010 Jun; 584(11):2315-20. PubMed ID: 20371366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tonggyu-tang, a traditional Korean medicine, suppresses pro-inflammatory cytokine production through inhibition of MAPK and NF-κB activation in human mast cells and keratinocytes.
    Kim HI; Hong SH; Ku JM; Kang S; Kim TY; Shin YC; Ko SG
    BMC Complement Altern Med; 2017 Mar; 17(1):186. PubMed ID: 28359265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.